| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 9.60 | -0.04 (-0.41%) | 7.23 - 9.64 | 0.0 |
Market data as of 6:05PM 05/21/13. Quotes are delayed by at least 15 min.
The investment seeks long-term capital appreciation; with current income as a secondary objective. The fund invests at least 80% of assets, determined at the time of purchase, in the stocks and other securities with equity characteristics of non-US companies. It typically achieves its equity exposure to non-US equity companies through investing in American Depositary Receipts (ADRs), but it is not limited to making investments in ADRs. The fund may invest up to 50% of its assets in emerging markets securities. Its equity investments are mainly common stocks, but may also include other types of equities such as preferred stocks or convertible securities.
| Total Return | 0.79% |
|---|---|
| Yield (Trailing 12 Mo.) | 1.62% |
| Expense Ratio | 1.52% |
| Front Load | 5.75% |
| Deferred Load | None |
| Minimum Investment | $1,000 |
| Management Tenure | 3 Years |
| Fund Inception | 07/05/2006 |
| Timeframe | DNVAX | S&P 500 | Foreign Large Value |
|---|---|---|---|
| 1 Month | 3.88% | 1.93% | 4.87% |
| 3 Month | -1.06% | 7.18% | 3.92% |
| Year-to-Date | 2.63% | 12.74% | 8.31% |
| 1 Year | 13.83% | 16.89% | 17.03% |
| 3 Year | 4.61% | 12.80% | 6.02% |
| 5 Year | -3.74% | 5.21% | -1.76% |
| 10 Year | -- | 7.88% | 8.69% |
| Since Inception | 0.79% | 10.38% | -- |
| Basic Materials | 12.35% | |
|---|---|---|
| Consumer Cyclical | 6.13% | |
| Financial Services | 28.58% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 4.16% | |
| Healthcare | 6.61% | |
| Utilities | 0.00% | |
| Communication Services | 10.18% | |
| Energy | 18.03% | |
| Industrials | 10.29% | |
| Technology | 3.67% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 1.58 | 1.58 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.31 | 0.00 | -0.31 | ||
| Foreign Stock | 0.00 | 98.73 | 98.73 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.31 | 100.31 | 100.00 | ||
| Cash | 0.00 | 0.00 | 0.00 | ||
| Total Net Assets | $175.17M |
|---|---|
| Total Stock Holdings | 49 |
| Total Bond Holdings | 0 |
| Valuation | DNVAX | Category Range |
|---|---|---|
| Price/Earnings | 11.18 | |
| Price/Book | 1.07 | |
| Price/Sales | 0.84 | |
| Price/Cash Flow | 5.26 | |
| Dividend Yield | 3.05 | |
| LT Earnings | 8.3 | |
| Historical Earnings | 9.3 | |
| Sales Growth | 2.76 | |
| Cash-Flow Growth | 0.15 | |
| Book-Value Growth | 5.58 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Above Avg | |
| Return | Low |
| Pretax Return | 4.61% |
|---|---|
| Tax-adjusted Return | 2.00% |
| Tax Cost Ratio | 0.54% |
| Potential Cap Gains | -45.85% |
